Jeremie Vitte, PhD - University of California, Los Angeles

Jeremie Vitte

PhD

University of California, Los Angeles

Los Angeles, California | United States

ORCID logohttps://orcid.org/0000-0002-2567-7988

Jeremie Vitte, PhD - University of California, Los Angeles

Jeremie Vitte

PhD

Introduction

Primary Affiliation: University of California, Los Angeles - Los Angeles, California , United States

Experience

Dec 2013 - Jun 2018
University of California Los Angeles - David Geffen School of Medicine
Assistant Researcher
Department of Head and Neck Surgery
Jan 2011 - Jan 2013
House Research Institute
Senior Research Associate/Staff Scientist
Neural Tumor Research Laboratory
Jan 2009 - Jan 2011
House Research Institute
Postdoctoral Scientist
Neural Tumor Research Laboratory
Jan 2008 - Jan 2009
INSERM - Hôpital Pitié Salpêtrière
Postdoctoral Scientist
Neurology and Experimental Therapeutics Laboratory
Jul 2018
University of California Los Angeles David Geffen School of Medicine
Associate Project Scientist
Department of Head and Neck Surgery

Publications

17Publications

348Reads

-Profile Views

233PubMed Central Citations

Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.

J Neurooncol 2018 Mar 11;137(1):33-38. Epub 2017 Dec 11.

Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Medical Genetics Unit, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2711-6DOI Listing
March 2018
7 Reads
3.070 Impact Factor

Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.

Nat Commun 2017 08 21;8(1):300. Epub 2017 Aug 21.

Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA and Jonsson Comprehensive Cancer Center (JCCC), University of California Los Angeles, Los Angeles, CA, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-00346-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563506PMC
August 2017
14 Reads
10.742 Impact Factor

An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth.

J Neurooncol 2016 08 13;129(1):47-56. Epub 2016 May 13.

Department of Head and Neck Surgery, University of California Los Angeles, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2150-9DOI Listing
August 2016
8 Reads
3 Citations
3.070 Impact Factor

Expanding the mutational spectrum of LZTR1 in schwannomatosis.

Eur J Hum Genet 2015 Jul 22;23(7):963-8. Epub 2014 Oct 22.

Department of Biomedical Experimental and Clinical Sciences, Medical Genetics, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2014.220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463507PMC
July 2015
36 Reads
6 Citations
4.350 Impact Factor

mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.

Neuro Oncol 2014 Apr 10;16(4):493-504. Epub 2014 Jan 10.

House Research Institute, Center for Neural Tumor Research, Los Angeles, CA, USA (M.G., N.-X.B., J.V., F.C., K.T., R.A., L.M.F.); Department of Cell and Neurobiology, University of Southern California, Keck School of Medicine, Los Angeles, California (M.G.); Département de Dermatologie, Centre de référence des neurofibromatoses, Hôpital Henri-Mondor, AP-HP and EA 4393 LIC, Université Paris Est Créteil, Créteil, France (L.V.-A., P.W.); Department of Neurosurgery, AP-HP, Hopital Beaujon, Clichy, France (S.G); Department of Neurosurgery, AP-HP, Hôpital Pitié Salpêtrière, Paris Cedex 13, France (M.K.); Université Pierre et Marie Curie, Faculté de Médecine, Paris Cedex 13, France (M.K.); Unité Inserm U674, Fondation Jean Dausset, Paris, France (S.G., M.K.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/not242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956353PMC
April 2014
15 Reads
18 Citations
5.562 Impact Factor

Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.

Clin Cancer Res 2013 Jul 28;19(14):3856-70. Epub 2013 May 28.

Center for Neural Tumor Research and Section on Genetics of Hereditary Ear Disorders, House Research Institute, University of California, Los Angeles, CA 90057, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2013/05/
Web Search
http://clincancerres.aacrjournals.org/content/clincanres/ear
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-12-3167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331126PMC
July 2013
29 Reads
10 Citations
8.722 Impact Factor

Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease.

J Neuropathol Exp Neurol 2010 Sep;69(9):959-72

Laboratory of Molecular Basis, Physiopathology and Treatment of Neurodegenerative Diseases, Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0b013e3181efc01cDOI Listing
September 2010
37 Reads
22 Citations
3.800 Impact Factor

Spinal muscular atrophy.

Adv Exp Med Biol 2009 ;652:237-46

Department of Human Genetics, Hadassah University Hospital, PO Box 91120, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-90-481-2813-6_16DOI Listing
April 2010
9 Reads
2 Citations

Refined characterization of the expression and stability of the SMN gene products.

Am J Pathol 2007 Oct 23;171(4):1269-80. Epub 2007 Aug 23.

Molecular Neurogenetics Laboratory, INSERM U798, Evry and Paris 11 Universities, Evry, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2007.070399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1988876PMC
October 2007
8 Reads
35 Citations
4.591 Impact Factor